Cite
Effects of Momordica Charantia (Karela/bitterguord) in Type 2 Diabetic Patients Taking Allopathic Drugs: A pilot study
MLA
G P, Rauniyar, et al. “Effects of Momordica Charantia (Karela/Bitterguord) in Type 2 Diabetic Patients Taking Allopathic Drugs: A Pilot Study.” Kathmandu University Medical Journal (KUMJ), vol. 19, no. 74, Nov. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........899ca9b5721c4febe8b4cc835287ae12&authtype=sso&custid=ns315887.
APA
G P, R., R, S., K, C., R, M., & D R, P. (2021). Effects of Momordica Charantia (Karela/bitterguord) in Type 2 Diabetic Patients Taking Allopathic Drugs: A pilot study. Kathmandu University Medical Journal (KUMJ), 19(74).
Chicago
G P, Rauniyar, Sinha R, Chapagain K, Maskey R, and Pandey D R. 2021. “Effects of Momordica Charantia (Karela/Bitterguord) in Type 2 Diabetic Patients Taking Allopathic Drugs: A Pilot Study.” Kathmandu University Medical Journal (KUMJ) 19 (74). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........899ca9b5721c4febe8b4cc835287ae12&authtype=sso&custid=ns315887.